rutecarpine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, N; Dong, TT; Guo, H; Lee, HC; Leung, KW; Lin, S; Miller, AL; Tang, RW; Tsim, KW; Wang, X; Webb, SE | 1 |
1 other study(ies) available for rutecarpine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Ethanol Extract of Evodiae Fructus and Its Ingredient, Rutaecarpine, Inhibit Infection of SARS-CoV-2 and Inflammatory Responses.
Topics: COVID-19; Drugs, Chinese Herbal; Evodia; Humans; Plant Extracts; SARS-CoV-2 | 2023 |